Ginsenoside Compound K Inhibits Pancreatic Cancer by Induction of Canonical Pyroptosis Associated with HAPLN1 Signaling
- 1Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, Biotech & Biomed Research Institute, School of Chemical Engineering, Northwest University, Xi’an 710127, China
- 2College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China
- 3State Key Laboratory of Vegetable Biobreeding, Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Beijing 100081, China
Abstract
Background: Pancreatic cancer (PC) remains one of the most lethal malignancies because of its highly immunosuppressive tumor microenvironment and profound resistance to current therapies. Increasing evidence suggests that pyroptosis, a pro-inflammatory form of programmed cell death, may provide a promising strategy for enhancing anti-tumor immunity and improving therapeutic responsiveness. Ginsenoside Compound K (CK), a major bioactive intestinal metabolite of Panax ginseng, exhibits diverse pharmacological and anti-tumor activities. However, whether its anti-PC effects involve the induction of tumor cell pyroptosis remains unclear. Methods: The anti-tumor effects and underlying mechanisms of CK were investigated in Panc02 tumor-bearing mice and BxPC-3 pancreatic cancer cells. Tumor growth, systemic toxicity, pyroptosis-related events, reactive oxygen species (ROS) production and the involvement of the HAPLN1–TNFα/NF-κB signaling pathway were evaluated. Pharmacological inhibition of ROS and caspase-1 was employed to verify the mechanism of CK-induced pyroptosis. Results: CK significantly suppressed tumor growth without causing apparent systemic toxicity and induced characteristic pyroptotic changes, including caspase-1 activation, enhanced lactate dehydrogenase release, and disruption of mitochondrial membrane potential. Mechanistically, CK promoted intracellular ROS accumulation and activated the HAPLN1–TNFα/NF-κB axis, leading to NLRP3 inflammasome activation and subsequent cleavage of caspase-1 and gasdermin D (GSDMD). And either ROS scavenging or caspase-1 inhibition markedly attenuated CK-induced pyroptosis. Conclusions: CK exerts potent anti-pancreatic cancer activity by promoting ROS/NLRP3-dependent pyroptosis and is associated with HAPLN1-related inflammatory signaling, supporting its further development as a therapeutic candidate for pancreatic cancer.
Related
- Ginsenoside Re attenuates severe acute pancreatitis-associated acute lung injury by inhibiting pancreatic necroptosis-driven cfDNA release and pulmonary cGAS-STING activation
- Venetoclax Resistance Creates Canonical Pyroptosis Vulnerability in AML
- Synergistic induction of pyroptosis-like cell death in colorectal cancer cells by norcantharidin and low-dose oxaliplatin promotes M1 macrophage polarization
- ER stress-associated apoptosis and pyroptosis-like changes in Kikuchi–Fujimoto disease
- Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis
BibTeX
@article{liu2026ginsenoside,
title = {{Ginsenoside Compound K Inhibits Pancreatic Cancer by Induction of Canonical Pyroptosis Associated with HAPLN1 Signaling}},
author = {Jingke Liu and Chao Fang and Haixia Yang and Daidi Fan and Jianjun Deng},
journal = {Nutrients},
year = {2026},
month = nov,
doi = {10.3390/nu18223757},
url = {https://www.mdpi.com/2072-6643/18/22/3757},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Ginsenoside Compound K Inhibits Pancreatic Cancer by Induction of Canonical Pyroptosis Associated with HAPLN1 Signaling
AU - Jingke Liu
AU - Chao Fang
AU - Haixia Yang
AU - Daidi Fan
AU - Jianjun Deng
PY - 2026
DA - 2026/11/12
JO - Nutrients
DO - 10.3390/nu18223757
UR - https://www.mdpi.com/2072-6643/18/22/3757
AB - Background: Pancreatic cancer (PC) remains one of the most lethal malignancies because of its highly immunosuppressive tumor microenvironment and profound resistance to current therapies. Increasing evidence suggests that pyroptosis, a pro-inflammatory form of programmed cell death, may provide a promising strategy for enhancing anti-tumor immunity and improving therapeutic responsiveness. Ginsenoside Compound K (CK), a major bioactive intestinal metabolite of Panax ginseng, exhibits diverse pharmacological and anti-tumor activities. However, whether its anti-PC effects involve the induction of tumor cell pyroptosis remains unclear. Methods: The anti-tumor effects and underlying mechanisms of CK were investigated in Panc02 tumor-bearing mice and BxPC-3 pancreatic cancer cells. Tumor growth, systemic toxicity, pyroptosis-related events, reactive oxygen species (ROS) production and the involvement of the HAPLN1–TNFα/NF-κB signaling pathway were evaluated. Pharmacological inhibition of ROS and caspase-1 was employed to verify the mechanism of CK-induced pyroptosis. Results: CK significantly suppressed tumor growth without causing apparent systemic toxicity and induced characteristic pyroptotic changes, including caspase-1 activation, enhanced lactate dehydrogenase release, and disruption of mitochondrial membrane potential. Mechanistically, CK promoted intracellular ROS accumulation and activated the HAPLN1–TNFα/NF-κB axis, leading to NLRP3 inflammasome activation and subsequent cleavage of caspase-1 and gasdermin D (GSDMD). And either ROS scavenging or caspase-1 inhibition markedly attenuated CK-induced pyroptosis. Conclusions: CK exerts potent anti-pancreatic cancer activity by promoting ROS/NLRP3-dependent pyroptosis and is associated with HAPLN1-related inflammatory signaling, supporting its further development as a therapeutic candidate for pancreatic cancer.
SN - 2072-6643
ER -